Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""middle east"" wg kryterium: Temat


Tytuł:
Viral shadows in the Middle East: Revisiting MERS-CoV Post SARS-CoV2.
Autorzy:
Shenagari M; Department of Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. Electronic address: .
Mohammadi-Pilehdarboni H; Queen Mary University of London, London, United Kingdom.
Pokaż więcej
Źródło:
Journal of infection and public health [J Infect Public Health] 2024 Mar; Vol. 17 (3), pp. 476-477. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Letter
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*/genetics
COVID-19*
Humans ; RNA, Viral ; SARS-CoV-2 ; Middle East/epidemiology
Opinia redakcyjna
Tytuł:
MERS-CoV seroconversion amongst Malaysian Hajj pilgrims returning from the Middle East, 2016-2018: results from the MERCURIAL multiyear prospective cohort study.
Autorzy:
Johari J; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Hontz RD; U.S. Naval Medical Research Center - Asia, Singapore, Singapore.
Pike BL; U.S. Naval Medical Research Center - Asia, Singapore, Singapore.
Husain T; U.S. Naval Medical Research Center - Asia, Singapore, Singapore.
Rusli N; Ministry of Health Malaysia, Putrajaya, Malaysia.
Mohd-Zain R; Ministry of Health Malaysia, Putrajaya, Malaysia.
Tiong V; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Lee HY; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Teoh BT; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Sam SS; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Khor CS; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Loong SK; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Abd-Jamil J; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Nor'e SS; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Yahaya H; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Che-Kamaruddin N; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Garcia-Rivera JA; U.S. Naval Medical Research Unit - 2, Phnom Penh, Cambodia.
AbuBakar S; Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2208678.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*
Coronavirus Infections*
Animals ; Camelus ; Prospective Studies ; Cohort Studies ; Seroconversion ; Middle East/epidemiology ; Travel ; Saudi Arabia/epidemiology
Czasopismo naukowe
Tytuł:
Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins.
Autorzy:
Azhar EI; Special Infectious Agents Unit Biosafety Level-3, King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: .
Velavan TP; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Vietnamese-German Center for Medical Research, Hanoi, Vietnam.
Rungsung I; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Vietnamese-German Center for Medical Research, Hanoi, Vietnam.
Traore T; Emergency Preparedness and Response Program, World Health Organization Regional Office for Africa, Dakar Hub, Senegal.
Hui DS; Department of Medicine and Therapeutics, Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.
McCloskey B; Global Health Program, Chatham House, Royal Institute of International Affairs, London, United Kingdom.
El-Kafrawy SA; Special Infectious Agents Unit Biosafety Level-3, King Fahd Medical Research Center and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Zumla A; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom; National Institute for Health and Care Research Biomedical Research Centre, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Jun; Vol. 131, pp. 87-94. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*/genetics
Coronavirus Infections*/epidemiology
Coronavirus Infections*/veterinary
Animals ; Humans ; Camelus ; Phylogeny ; Middle East/epidemiology ; Saudi Arabia/epidemiology ; Genomics
Czasopismo naukowe
Tytuł:
Respiratory virus detection in returning travelers and pilgrims from the Middle East.
Autorzy:
Mercier A; Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: .
Méheut A; CHU Lille, Service des Maladies Infectieuses et Tropicales, Lille, France, F-59037, Lille, France. Electronic address: .
Alidjinou EK; Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: .
Lazrek M; Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: .
Faure K; CHU Lille, Service des Maladies Infectieuses et Tropicales, Lille, France, F-59037, Lille, France; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France; Service de Maladies Infectieuses, CHU Lille, F-59000, Lille, France. Electronic address: .
Hober D; Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: .
Engelmann I; Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59037, Lille, France. Electronic address: .
Pokaż więcej
Źródło:
Travel medicine and infectious disease [Travel Med Infect Dis] 2023 Jan-Feb; Vol. 51, pp. 102482. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Middle East Respiratory Syndrome Coronavirus*/genetics
Viruses*
Orthomyxoviridae*
Humans ; Retrospective Studies ; Middle East/epidemiology ; Saudi Arabia/epidemiology
Czasopismo naukowe
Tytuł:
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023.
Autorzy:
Ogoti BM
Riitho V
Wildemann J
Mutono N
Tesch J
Rodon J
Harichandran K
Emanuel J
Möncke-Buchner E
Kiambi S
Oyugi J
Mureithi M
Corman VM
Drosten C
Thumbi SM
Müller MA
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Mar; Vol. 30 (3), pp. 581-585.
Typ publikacji:
Journal Article
MeSH Terms:
Camelus*
Middle East Respiratory Syndrome Coronavirus*
Humans ; Animals ; Kenya/epidemiology ; Incidence ; Abattoirs
Czasopismo naukowe
Tytuł:
A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface.
Autorzy:
Mani G; School of Science, Western Sydney University, Penrith, New South Wales, Australia.
El-Kamand S; School of Science, Western Sydney University, Penrith, New South Wales, Australia.
Wang B; Department of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Baker DL; School of Science, Western Sydney University, Penrith, New South Wales, Australia.
Ataide SF; School of Life and Environmental Sciences, University of Sydney, Camperdown, New South Wales, Australia.
Artsimovitch I; Department of Microbiology, The Ohio State University, Columbus, Ohio, USA.
Cubeddu L; School of Science, Western Sydney University, Penrith, New South Wales, Australia.; School of Life and Environmental Sciences, University of Sydney, Camperdown, New South Wales, Australia.
Gamsjaeger R; School of Science, Western Sydney University, Penrith, New South Wales, Australia.; School of Life and Environmental Sciences, University of Sydney, Camperdown, New South Wales, Australia.
Pokaż więcej
Źródło:
Proteins [Proteins] 2024 Mar; Vol. 92 (3), pp. 418-426. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*/genetics
Middle East Respiratory Syndrome Coronavirus*/metabolism
Humans ; SARS-CoV-2/metabolism ; Viral Nonstructural Proteins/genetics ; Viral Nonstructural Proteins/metabolism ; RNA/metabolism
Czasopismo naukowe
Tytuł:
Neutralizing immunity against coronaviruses in Tanzanian health care workers.
Autorzy:
Barabona G; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Ngare I; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Kamori D; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Nkinda L; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Kosugi Y; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mawazo A; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ekwabi R; Amana Regional Referral Hospital, Dar es Salaam, Tanzania.
Kinasa G; Aga Khan Hospital, Dar es Salaam, Tanzania.
Chuwa H; Aga Khan Hospital, Dar es Salaam, Tanzania.
Sato K; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; CREST, Japan Science and Technology Agency, Kawaguchi, Japan.
Sunguya B; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.; Department of Community Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ueno T; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. .; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. .
Pokaż więcej
Corporate Authors:
Genotype to Phenotype Japan (G2P-Japan) Consortium
Źródło:
Scientific reports [Sci Rep] 2024 Mar 06; Vol. 14 (1), pp. 5508. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*
Coronavirus NL63, Human*
Humans ; Seroepidemiologic Studies ; Tanzania ; Health Personnel ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic.
Autorzy:
Kim SH; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Kim Y; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Institute of Endemic Disease, Seoul National University Medical Research, Seoul 03080, Republic of Korea.
Jeon S; Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea.
Park U; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Kang JI; Institute of Endemic Disease, Seoul National University Medical Research, Seoul 03080, Republic of Korea.
Jeon K; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Kim HR; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Oh S; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Rhee JY; Division of Infectious Diseases, Department of Medicine, Dankook University College of Medicine, Cheonan 31116, Republic of Korea.
Choi JP; Department of Internal Medicine, Seoul Medical Center, Seoul 02053, Republic of Korea.
Park WB; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Park SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Yang JS; Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Lee JY; Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
Kang J; Translational Research Center, Research Institute of Public Health, National Medical Center, Seoul 04564, Republic of Korea.
Shin HS; Division of Infectious Diseases, Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon 34824, Republic of Korea.
Kim Y; Center for Infectious Diseases, National Medical Center, Seoul 04564, Republic of Korea.
Kim S; Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea.
Kim YS; Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea.
Lim DG; Translational Research Center, Research Institute of Public Health, National Medical Center, Seoul 04564, Republic of Korea.
Cho NH; Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.; Institute of Endemic Disease, Seoul National University Medical Research, Seoul 03080, Republic of Korea.; Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do 13620, Republic of Korea.
Pokaż więcej
Źródło:
Science advances [Sci Adv] 2024 Mar; Vol. 10 (9), pp. eadk6425. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Middle East Respiratory Syndrome Coronavirus*
Humans ; COVID-19 Vaccines ; Pandemics ; Follow-Up Studies ; SARS-CoV-2 ; Adaptive Immunity ; Epitopes
Czasopismo naukowe
Tytuł:
Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models.
Autorzy:
Zhang Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Sun J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Zheng J; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, 52242, USA.
Li S; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Rao H; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Dai J; Guangzhou Customs District Technology Center, Guangzhou, 510700, P. R. China.
Zhang Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Wang Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Liu D; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Chen Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Ran W; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Zhu A; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Li F; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Yan Q; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Wang Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Yu K; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Zhang S; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Wang D; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Tang Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Liu B; State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, P. R. China.
Cheng L; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.
Huo J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.; Guangzhou laboratory, Bio-island, Guangzhou, 510320, P. R. China.
Perlman S; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, 52242, USA.
Zhao J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.; Guangzhou laboratory, Bio-island, Guangzhou, 510320, P. R. China.
Zhao J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510300, P. R. China.; Guangzhou laboratory, Bio-island, Guangzhou, 510320, P. R. China.; Institute of Infectious disease, Guangzhou Eighth People's Hospital of Guangzhou Medical University, Guangzhou, 510060, P. R. China.; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, the Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, 518112, P. R. China.; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Pokaż więcej
Źródło:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Mar; Vol. 11 (9), pp. e2303366. Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:
Journal Article
MeSH Terms:
Viral Vaccines*
Coronavirus Infections*/prevention & control
Middle East Respiratory Syndrome Coronavirus*/chemistry
Nanoparticles*
Humans ; Animals ; Mice ; Antibodies, Neutralizing ; Antibodies, Viral ; SARS-CoV-2 ; Models, Animal
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
An enhanced broad-spectrum peptide inhibits Omicron variants in vivo.
Autorzy:
Bi W; Research Center for Industries of the Future and Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310030, Zhejiang, China; Frontier Biotechnology Laboratory, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou 311215, China; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310030, Zhejiang, China; Institute of Biology, Westlake Institute for Advanced Study, Hangzhou 310030, China. Electronic address: .
Tang K; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China; State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
Chen G; Research Center for Industries of the Future and Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310030, Zhejiang, China; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310030, Zhejiang, China; Institute of Biology, Westlake Institute for Advanced Study, Hangzhou 310030, China.
Xie Y; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China; State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
Polizzi NF; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
DeGrado WF; Department of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California at San Francisco, San Francisco, CA 94158, USA.
Yuan S; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China; State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China. Electronic address: .
Dang B; Research Center for Industries of the Future and Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310030, Zhejiang, China; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310030, Zhejiang, China; Institute of Biology, Westlake Institute for Advanced Study, Hangzhou 310030, China. Electronic address: .
Pokaż więcej
Źródło:
Cell reports. Medicine [Cell Rep Med] 2024 Feb 20; Vol. 5 (2), pp. 101418. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*
Animals ; Mice ; Administration, Intranasal ; Mice, Transgenic ; Peptides/pharmacology ; SARS-CoV-2/genetics ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Targeting protein-protein interaction interfaces with antiviral N protein inhibitor in SARS-CoV-2.
Autorzy:
Hong JY; Institute of Genomics and Bioinformatics and Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
Lin SC; Bachelor Degree Program in Marine Biotechnology, College of Life Sciences, National Taiwan Ocean University, Keelung, Taiwan.
Kehn-Hall K; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia; Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, Virginia.
Zhang KM; Department of Chemistry, National Chung Hsing University, Taichung, Taiwan.
Luo SY; Department of Chemistry, National Chung Hsing University, Taichung, Taiwan.
Wu HY; Graduate Institute of Veterinary Pathobiology, College of Veterinary Medicine, National Chung Hsing University. Taichung, Taiwan.
Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Hou MH; Institute of Genomics and Bioinformatics and Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan; PhD Program in Medical Biotechnology, National Chung Hsing University, Taichung, Taiwan; Biotechnology Center, National Chung Hsing University, Taichung, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Biophysical journal [Biophys J] 2024 Feb 20; Vol. 123 (4), pp. 478-488. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Middle East Respiratory Syndrome Coronavirus*/chemistry
Humans ; SARS-CoV-2 ; Benzene ; Antiviral Agents/pharmacology
Czasopismo naukowe
Tytuł:
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.
Autorzy:
Li P; Department of Microbiology and Immunology, The University of Iowa, lowa, USA.
Kim Y; Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
Dampalla CS; Department of Chemistry, Wichita State University, Wichita, Kansas, USA.
Nhat Nguyen H; Department of Chemistry, Wichita State University, Wichita, Kansas, USA.
Meyerholz DK; Department of Pathology, The University of Iowa, Iowa, USA.
Johnson DK; Computational Chemical Biology Core, The University of Kansas, Lawrence, Kansas, USA.
Lovell S; Protein Structure Laboratory, The University of Kansas, Lawrence, Kansas, USA.
Groutas WC; Department of Chemistry, Wichita State University, Wichita, Kansas, USA.
Perlman S; Department of Microbiology and Immunology, The University of Iowa, lowa, USA.
Chang K-O; Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Feb 14; Vol. 15 (2), pp. e0287823. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*
COVID-19*
Hepatitis C, Chronic*
Humans ; Mice ; Animals ; SARS-CoV-2 ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
The Main Protease of Middle East Respiratory Syndrome Coronavirus Induces Cleavage of Mitochondrial Antiviral Signaling Protein to Antagonize the Innate Immune Response.
Autorzy:
van Huizen M; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Vendrell XM; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
de Gruyter HLM; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Boomaars-van der Zanden AL; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
van der Meer Y; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Snijder EJ; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Kikkert M; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Myeni SK; Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 05; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*
Immunity, Innate ; Interferon-beta/metabolism ; Peptide Hydrolases ; Antiviral Agents
Czasopismo naukowe
Tytuł:
Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin.
Autorzy:
Yang J; The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Song Y; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Jin W; College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.
Xia K; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Burnett GC; Department of Cell & Molecular Biology, The University of Mississippi Medical Center, Jackson, MS 39216, USA.
Qiao W; The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.
Bates JT; Department of Cell & Molecular Biology, The University of Mississippi Medical Center, Jackson, MS 39216, USA.
Pomin VH; Department of BioMolecular Sciences, Research Institute of Pharmaceutical Sciences, The University of Mississippi, Oxford, MS 38677, USA.
Wang C; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Qiao M; The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.
Linhardt RJ; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.; Departments of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Dordick JS; Departments of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Zhang F; Departments of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 02; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/pharmacology
Middle East Respiratory Syndrome Coronavirus*/metabolism
Animals ; Sulfates/chemistry ; Glycosaminoglycans/metabolism ; Heparitin Sulfate/metabolism ; Mammals
Czasopismo naukowe
Tytuł:
Single amino acid substitution and inter-species transmission of MERS-coronavirus from camels to humans: abridged secondary publication.
Autorzy:
Peiris JSM; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
So RTY; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Poon LLM; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Chu KW; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Mok CKP; School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
Zhao J; State Key Laboratory of Respiratory Disease, Guangzhou, China.
Pokaż więcej
Źródło:
Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2024 Feb; Vol. 30 Suppl 1 (1), pp. 9-15.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*/genetics
Coronavirus Infections*/epidemiology
Animals ; Humans ; Camelus ; Amino Acid Substitution
Czasopismo naukowe
Tytuł:
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID-19, avian influenza, and MERS-CoV.
Autorzy:
Mahmoud M; Human Link DMCC, Dubai, United Arab Emirates.
Badra R; Human Link DMCC, Dubai, United Arab Emirates.
Kandeil A; Human Link DMCC, Dubai, United Arab Emirates.; Center of Scientific Excellence for Influenza Virus, Institute of Environmental Research and Climate Changes, National Research Centre, Giza, Egypt.
El-Shesheny R; Human Link DMCC, Dubai, United Arab Emirates.; Center of Scientific Excellence for Influenza Virus, Institute of Environmental Research and Climate Changes, National Research Centre, Giza, Egypt.
Abdallah J; Multi-Omics Laboratory, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Ali MA; Center of Scientific Excellence for Influenza Virus, Institute of Environmental Research and Climate Changes, National Research Centre, Giza, Egypt.
Kayali G; Human Link DMCC, Dubai, United Arab Emirates.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13257.
Typ publikacji:
Journal Article
MeSH Terms:
Middle East Respiratory Syndrome Coronavirus*
Influenza in Birds*/epidemiology
COVID-19*/epidemiology
Humans ; Animals ; Pandemics/prevention & control ; Laboratories ; Mediterranean Region/epidemiology
Czasopismo naukowe
Tytuł:
SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
Autorzy:
Yang L; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Zeng XT; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Luo RH; Key Laboratory of Bioactive Peptides of Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
Ren SX; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Liang LL; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Huang QX; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Tang Y; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Fan H; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Ren HY; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Zhang WJ; Department of Pathophysiology, Shihezi University School of Medicine, the Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi, Xinjiang, China.
Zheng YT; Key Laboratory of Bioactive Peptides of Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
Cheng W; Division of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2024 Jan; Vol. 96 (1), pp. e29396.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/genetics
Middle East Respiratory Syndrome Coronavirus*/genetics
Humans ; SARS-CoV-2/genetics ; SARS-CoV-2/metabolism ; RNA-Dependent RNA Polymerase/metabolism ; RNA Splicing Factors
Czasopismo naukowe
Tytuł:
Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
Autorzy:
Gallucci L; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Bazire J; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Davidson AD; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Electronic address: .
Shytaj IL; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Electronic address: .
Pokaż więcej
Źródło:
Antiviral research [Antiviral Res] 2024 Jan; Vol. 221, pp. 105766. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coronavirus Infections*/drug therapy
Middle East Respiratory Syndrome Coronavirus*
Humans ; Antiviral Agents/therapeutic use ; Ritonavir/pharmacology ; Cytochrome P-450 CYP3A Inhibitors/pharmacology ; Cytochrome P-450 CYP3A Inhibitors/therapeutic use ; Cobicistat/therapeutic use
Czasopismo naukowe
Tytuł:
Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies.
Autorzy:
Li J; College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, 26 Yuxiang Street, Shijiazhuang 050018, China; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Li Q; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Xia S; Key Laboratory of Medical Molecular Virology of MOE/MOH/CAMS, Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, 131 Dong An Road, Shanghai 200032, China.
Tu J; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Zheng L; Key Laboratory of Structure-based Drug Design & Discovery of the Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wang Q; Key Laboratory of Medical Molecular Virology of MOE/MOH/CAMS, Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, 131 Dong An Road, Shanghai 200032, China.
Jiang S; Key Laboratory of Medical Molecular Virology of MOE/MOH/CAMS, Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, 131 Dong An Road, Shanghai 200032, China. Electronic address: .
Wang C; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing 100850, China. Electronic address: .
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 Jan 01; Vol. 97, pp. 129569. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents*/pharmacology
Antiviral Agents*/chemistry
Middle East Respiratory Syndrome Coronavirus*/drug effects
Peptides/chemistry ; Protein Conformation, alpha-Helical ; Lipopeptides/pharmacology ; Lipopeptides/therapeutic use
Czasopismo naukowe
Tytuł:
The insights from SARS-CoV-2 antibody treatment for future emerging infectious diseases.
Autorzy:
Wang Y; National Center for Respiratory Medicine, Beijing, China; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Cao B; National Center for Respiratory Medicine, Beijing, China; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: caobin_.
Pokaż więcej
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jan; Vol. 24 (1), pp. 2-3. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Communicable Diseases, Emerging*/drug therapy
Middle East Respiratory Syndrome Coronavirus*
Humans ; SARS-CoV-2 ; Antibodies, Viral/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies